EXHIBIT BRegistration Rights Agreement • May 28th, 2008 • China Pharma Holdings, Inc. • Pharmaceutical preparations • New York
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this "Agreement") is dated as of May __, 2008, among China Pharma Holdings, Inc., a Delaware corporation (collectively with its predecessors, the "Company"), and the...Securities Purchase Agreement • May 28th, 2008 • China Pharma Holdings, Inc. • Pharmaceutical preparations • New York
ESCROW AGREEMENT This Escrow Agreement (the "Escrow Agreement") is made and entered into as of July 31, 2003 by and among: - Softstone, Inc., a Delaware corporation ("SOFS"); - Keith P. Boyd; - Gene F. Boyd; - Betty Boyd; - T S Electronics...Escrow Agreement • November 19th, 2003 • Ts Electronics Inc • Refuse systems
EXHIBIT 10.2 SUBSCRIPTION AGREEMENT To: Onny Investment Limited Ladies and Gentlemen: The undersigned subscriber ("Subscriber") hereby tenders this Subscription Agreement (this "Agreement") in accordance with and subject to the terms and conditions...Subscription Agreement • October 20th, 2005 • Ts Electronics Inc • Refuse systems
R E C I T A L -------------Indemnity Agreement • February 15th, 2000 • Kilkenny Acquisition Corp • Delaware
RECITALSReorganization Agreement • November 19th, 2003 • Ts Electronics Inc • Refuse systems
May, 2005Ts Electronics Inc • October 20th, 2005 • Refuse systems
Exhibit 2.1 SECURITIES EXCHANGE AGREEMENT THIS SECURITIES EXCHANGE AGREEMENT (the "Agreement"), dated as of October 19, 2005 (the "Effective Date"), is entered into by and among ONNY INVESTMENT LIMITED, a company incorporated in the British Virgin...Securities Exchange Agreement • October 20th, 2005 • Ts Electronics Inc • Refuse systems • Delaware
Securities Purchase AgreementSecurities Purchase Agreement • November 23rd, 2021 • China Pharma Holdings, Inc. • Pharmaceutical preparations • Utah
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of November 17, 2021, is entered into by and between CHINA PHARMA HOLDINGS, INC., a Nevada corporation (“Company”), and STREETERVILLE CAPITAL, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”).
LOCKUP AGREEMENT ---------------- August __, 2003 TS Electronics Corporation ("TSEC") TS Electronics, XinMao Technology Park, D1, Suite 5C-DTianjin, China and Sherie Adams, C.L.A.S. (the "Custodian") Fuller, Tubb, Pomeroy and Stokes 201 Robert S. Kerr...Lockup Agreement • November 19th, 2003 • Ts Electronics Inc • Refuse systems
The undersigned shareholder ("Shareholder") is the legal and beneficial owner or the holder of record, as applicable, of shares of Common Stock, as indicated on the execution page of this Agreement (the "Shares"), of the company (the "Company") reorganized pursuant to that certain Reorganization Agreement dated as of July 31, 2003 among TSEC, Softstone, Inc. ("SOFS") and those certain parties thereto (the "Reorganization", and such agreement referred to herein as the "Reorganization Agreement").
Exhibit 10.1 SUBSCRIPTION AND REGISTRATION RIGHTS AGREEMENT CHINA PHARMA HOLDINGS, INC. Private Offering of up to 5,882,353 Units of Securities Purchase Price: $1.70 per Unit of Securities This Subscription and Registration Rights Agreement (this...Subscription and Registration Rights Agreement • February 6th, 2007 • China Pharma Holdings, Inc. • Pharmaceutical preparations • Delaware
INDENTURE Dated as of ____________, 20__ Between China Pharma Holdings, Inc. as Issuer And as Trustee Debt SecuritiesIndenture • February 6th, 2024 • China Pharma Holdings, Inc. • Pharmaceutical preparations • New York
INDENTURE dated as of __________, 20___, between China Pharma Holdings, Inc., a Nevada corporation (the “Company”), as issuer, and [_______________], a [__________] banking corporation, as Trustee (the “Trustee”).
ContractChina Pharma Holdings, Inc. • March 17th, 2009 • Pharmaceutical preparations
NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.
Exhibit 10.1 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (this "Agreement") is made and entered into as of the 11th day of May, 2005, by and between Halter Financial Group, Inc. ("Purchaser"), maintaining an address at 12890 Hilltop Road,...Stock Purchase Agreement • May 11th, 2005 • Ts Electronics Inc • Refuse systems • Texas
ContractChina Pharma Holdings, Inc. • April 1st, 2024 • Pharmaceutical preparations
Certain information marked as “xxx” has been excluded from the Agreement because it is both not material and is the type that the registrant treats as private or confidential
Sales contractChina Pharma Holdings, Inc. • March 28th, 2007 • Pharmaceutical preparations
EMPLOYMENT AGREEMENTEmployment Agreement • June 1st, 2011 • China Pharma Holdings, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT is made and entered into on May 31, 2011 (the “Agreement”), by and between CHINA PHARMA HOLDINGS, INC., a Delaware corporation (the “Company”), having its principal place of business at 2nd floor, No. 17 Jinpan Rd. Haikou, Hainan, People’s Republic of China 570216, and Frank Waung (“Employee”), with United States Social Insurance No. ### ## #### (Collectively the “Parties”).
AMENDMENT TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • April 20th, 2023 • China Pharma Holdings, Inc. • Pharmaceutical preparations
This Amendment to Convertible Promissory Note (this “Amendment”) is entered into as of April 13, 2023, by and between Streeterville Capital, LLC, a Utah limited liability company (“Lender”), and China Pharma Holdings, Inc., a Nevada corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).
ContractChina Pharma Holdings, Inc. • April 1st, 2024 • Pharmaceutical preparations
Certain information marked as “xxx” has been excluded from the Agreement because it is both not material and is the type that the registrant treats as private or confidential
Loans Extension AgreementLoans Extension Agreement • March 14th, 2013 • China Pharma Holdings, Inc. • Pharmaceutical preparations
With respect to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the Company), the principal and accumulated interest totaled USD $1,354,567 and $17,122 respectively as of December 31, 2012. Because the Company temporarily did not have enough balance in its oversea account to repay the loans, Ms. Tsui and the Company unanimously agreed to extend the loans to December 31, 2013. The Company shall repay the principal and accumulated interest on December 31, 2013.
Exhibit 10.9 Anhui Fuyang Xinte Medical Purchase ContractChina Pharma Holdings, Inc. • March 31st, 2008 • Pharmaceutical preparations
Certain information marked as “xxx” has been excluded from the Agreement because it is both not material and is the type that the registrant treats as private or confidential LOANSETTLEMENT AGREEMENTChina Pharma Holdings, Inc. • April 1st, 2024 • Pharmaceutical preparations
Whereas, the two parties agreed to settle the Loan in the form of securities of the Company subject to proper corporate governance procedure.
CHINA PHARMA HOLDINGS, INC.2010 Shares Option Agreement • August 9th, 2010 • China Pharma Holdings, Inc. • Pharmaceutical preparations • Delaware
LOAN AGREEMENTChina Pharma Holdings, Inc. • August 14th, 2019 • Pharmaceutical preparations
The two parties above have reached the following agreements with regards to a loan based on equality, voluntariness and consensus.
Helpson Medical & Biotechnology Co., Ltd.China Pharma Holdings, Inc. • March 17th, 2009 • Pharmaceutical preparations
According to the related stipulation of "People's Republic of China Law of contract", after consulting unanimously, both sides sign this contract:
Technology Transfer ContractChina Pharma Holdings, Inc. • December 2nd, 2022 • Pharmaceutical preparations
In this contract, Party B owns a technical invention and creation of an ophthalmic oxygen enriched atomization therapeutic apparatus, has obtained a utility model patent (the utility model patent number is ZL 2022 2 0394857.6) and applied for an invention patent at the same time. Party A receives the utility model patent right of the technical invention and the patent application right of the invention, and Party B provides relevant technical services. Both parties have reached the following agreement on the transfer of the new utility patent right and the patent application right for invention of this technology through equal consultation, based on the true and full expression of their own wishes, and in accordance with relevant laws and regulations, which shall be strictly observed by both parties.
AMENDMENT AGREEMENT TO NON-QUALIFIED STOCK OPTION AGREEMENTS OF CHINA PHARMA HOLDINGS, INCAmendment Agreement • April 30th, 2012 • China Pharma Holdings, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDMENT AGREEMENT (this “Agreement”), dated as of April 28, 2012, is entered into by and between China Pharma Holdings, Inc., a Delaware corporation (the “Company”) and Frank Waung (the “Optionee”).
WARRANTChina Pharma Holdings, Inc. • June 27th, 2008 • Pharmaceutical preparations
Sales Contract of Helpson Medical & Biotechnology Co., Ltd.China Pharma Holdings, Inc. • March 4th, 2010 • Pharmaceutical preparations
According to the related stipulation of "People's Republic of China Law of contract", after consulting unanimously, both sides sign this contract:
Exhibit 10.12 Lease AgreementLease Agreement • March 12th, 2009 • China Pharma Holdings, Inc. • Pharmaceutical preparations
Sales Contract of Helpson Medical & Biotechnology Co., Ltd.China Pharma Holdings, Inc. • March 4th, 2010 • Pharmaceutical preparations
According to the related stipulation of "People's Republic of China Law of contract", after consulting unanimously, both sides sign this contract:
Date: 5 March 2006 contract no Signed at: Arrival port: custom no business noChina Pharma Holdings, Inc. • March 28th, 2007 • Pharmaceutical preparations
AMENDMENT #2 TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • May 30th, 2024 • China Pharma Holdings, Inc. • Pharmaceutical preparations
This Amendment #2 to Convertible Promissory Note (this “Amendment”) is entered into as of May 23, 2024, by and between Streeterville Capital, LLC, a Utah limited liability company (“Lender”), and China Pharma Holdings, Inc., a Nevada corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).
EMPLOYMENT AGREEMENTEmployment Agreement • August 9th, 2010 • China Pharma Holdings, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT is made and entered into as of April 28, 2010 (the “Agreement”), by and between CHINA PHARMA HOLDINGS, INC., a Delaware corporation (the “Company”), having its principal place of business at 2nd floor, No. 17 Jinpan Rd. Haikou, Hainan, People’s Republic of China 570216, and Frank Waung (“Employee”), with United States Social Insurance No. XXX XX XXXX (Collectively the “Parties”).
FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT pursuant to the OF CHINA PHARMA HOLDINGS, INCNon-Qualified Stock Option Agreement • June 1st, 2011 • China Pharma Holdings, Inc. • Pharmaceutical preparations • Delaware
THIS NON-QUALIFIED STOCK OPTION AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between China Pharma Holdings, Inc., a Delaware corporation (the “Company”), and the Optionee specified above, pursuant to the 2010 Long-Term Incentive Plan of the Company, as in effect and as amended from time to time (the “Plan”); and
